The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

September 2010

Volume 50, Issue 9

Pages 986–1095

  1. Review

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Drug Interactions
    6. Brief Report
    7. Letter to the Editor
    8. Abstracts
  2. Pharmacokinetics

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Drug Interactions
    6. Brief Report
    7. Letter to the Editor
    8. Abstracts
    1. Lisdexamfetamine Dimesylate: Linear Dose-Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open-Label Single-Dose Pharmacokinetic Study in Healthy Adult Volunteers (pages 1001–1010)

      Mr James Ermer, Mr Robert Homolka, Dr Patrick Martin, Dr Mary Buckwalter, Dr Jaideep Purkayastha and Dr Benno Roesch

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009357346

    2. Risperidone Long-Acting Injection: Pharmacokinetics Following Administration in Deltoid Versus Gluteal Muscle in Schizophrenic Patients (pages 1011–1021)

      Dr An Thyssen, Dr Sarah Rusch, Dr Virginie Herben, Dr Jorge Quiroz and Dr Erik Mannaert

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009355156

  3. Pharmacodynamics

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Drug Interactions
    6. Brief Report
    7. Letter to the Editor
    8. Abstracts
  4. Drug Interactions

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Drug Interactions
    6. Brief Report
    7. Letter to the Editor
    8. Abstracts
    1. A Proof-of-Concept and Drug-Drug Interaction Study of Pamapimod, a Novel p38 MAP Kinase Inhibitor, With Methotrexate in Patients With Rheumatoid Arthritis (pages 1031–1038)

      Dr Xiaoping Zhang, Dr Yue Huang, Dr Mercidita T. Navarro, Dr Grace Hisoire and Dr John P. Caulfield

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009357433

    2. Effect of a Single Gemfibrozil Dose on the Pharmacokinetics of Rosuvastatin in Bile and Plasma in Healthy Volunteers (pages 1039–1049)

      Dr Ebba Bergman, Mrs Elin M. Matsson, Dr Mikael Hedeland, Dr Ulf Bondesson, Dr Lars Knutson and Dr Hans Lennernäs

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009357432

  5. Brief Report

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Drug Interactions
    6. Brief Report
    7. Letter to the Editor
    8. Abstracts
    1. The Effect of Acid Reduction With a Proton Pump Inhibitor on the Pharmacokinetics of Lopinavir or Ritonavir in HIV-Infected Patients on Lopinavir/Ritonavir-Based Therapy (pages 1050–1055)

      Dr Edgar T. Overton, Dr Jean M. Tschampa, Dr Michael Klebert, Dr Mike Royal, Dr Mark Rodriguez, Ms Teresa Spitz, Ms GeYoul Kim, Dr Kristin E. Mondy and Dr Edward P. Acosta

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009357431

  6. Letter to the Editor

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Drug Interactions
    6. Brief Report
    7. Letter to the Editor
    8. Abstracts
    1. Is There an Association Between 5-Azacitidine and Ototoxicity? (pages 1056–1057)

      Afshan Malik, Seema Misbah, Colette Spaccavento and Ian Yudelman

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009360536

  7. Abstracts

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Drug Interactions
    6. Brief Report
    7. Letter to the Editor
    8. Abstracts

SEARCH

SEARCH BY CITATION